Nov 07, 2025 This Week in Cardiology
Episode description
Listener feedback on non-culprit PCI in STEMI, a major cardiac result in patients on hemodialysis, news on GLP-1 agonists, a dubious stroke trial, and an AHA preview are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
I Listener Feedback
- Meta-analysis of MI as a surrogate https://pubmed.ncbi.nlm.nih.gov/34694318/
- Compare Acute Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1701067
- DANAMI-3–PRIMULTI 10.1016/S0140-6736(15)60648-1 External Link
- CULPRIT-SHOCK https://www.nejm.org/doi/full/10.1056/NEJMoa1710261
II Huge Cardiac News for Patients with ESRD PISCES article EMBARGOED Till 1130 AM EST
- PISCES Trial www.nejm.org/doi/full/10.1056/NEJMoa2513032
- REDUCE-IT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1812792
- STRENGTH Trial https://jamanetwork.com/journals/jama/fullarticle/2773120
- FISH trial https://jamanetwork.com/journals/jama/fullarticle/1150094
III Obesity Agents
- White House announces deal with Lilly and Novo on GLP-1 drugs https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-shares-rise-trump-obesity-drug-deal-nears-2025-11-06/
Amylin Agonists
- Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial
- Eloralintide Phase 2 Study https://doi.org/10.1016/S0140-6736(25)02155-5
GLP-1 Comparisons
- SURMOUNT-5 Trial https://www.nejm.org/doi/10.1056/NEJMoa2416394
- Tirzepatide vs Semaglutide in 10-year CVD Risk Reduction https://doi.org/10.1093/ehjopen/oeaf117
IV A Problematic Trial in Stroke Care
V AHA Preview
AHA 2025: Mandrola's Four Trials to Look For https://www.medscape.com/viewarticle/aha-2025-mandrolas-four-trials-look-2025a1000u80
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net